Matthew T. Plavan, Chief Executive Officer at Arcadia Biosciences, Inc. (RKDA), bought 2,000 shares at $6.49 ($13K) on 2019-09-10, disclosed to the SEC on 2019-09-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.49 | 1,000 | $6K | 49.9% |
| 2 | $6.52 | 1,000 | $7K | 50.1% |
| Total | $6.50 avg | 2,000 | $13K | 100% |
| Filing → |
| ORGN | SELL | 2025-11-04 | $83K | — | Filing → |
| ORGN | SELL | 2025-03-07 | $8K | — | Filing → |
| ORGN | SELL | 2024-12-31 | $25K | — | Filing → |